Cite
HIV‐1 drug resistance among individuals who seroconverted in the ASPIRE dapivirine ring trial
MLA
Rahil Sethi, et al. “HIV‐1 Drug Resistance among Individuals Who Seroconverted in the ASPIRE Dapivirine Ring Trial.” Journal of the International AIDS Society, vol. 24, Nov. 2021. EBSCOhost, https://doi.org/10.1002/jia2.25833.
APA
Rahil Sethi, Daniel W. Szydlo, Amy Heaps, John W. Mellors, Urvi M. Parikh, Elias K. Halvas, William E. Schwarzmann, Jared M. Baeten, Uma R. Chandran, Thesla Palanee-Phillips, Marla Husnik, Russell L. Hardesty, Kelley C. Gordon, Mtn Study Team, B Jay Goetz, & Kerri J. Penrose. (2021). HIV‐1 drug resistance among individuals who seroconverted in the ASPIRE dapivirine ring trial. Journal of the International AIDS Society, 24. https://doi.org/10.1002/jia2.25833
Chicago
Rahil Sethi, Daniel W. Szydlo, Amy Heaps, John W. Mellors, Urvi M. Parikh, Elias K. Halvas, William E. Schwarzmann, et al. 2021. “HIV‐1 Drug Resistance among Individuals Who Seroconverted in the ASPIRE Dapivirine Ring Trial.” Journal of the International AIDS Society 24 (November). doi:10.1002/jia2.25833.